A New and Effective Chitosan Therapeutic for Treatment of Severe Bleeding
BC3 technologies careers
BC3 Technologies has developed a novel chitosan spray that contains a particularly active form of chitosan. Chitosan is well-suited for treatment of severely bleeding wounds, due to its dual anti-hemorrhagic and antimicrobial properties.
BC3 technologies hasn't added any jobs yet
Get notified when BC3 technologies posts new jobs.
Wayne Grube Jr.
CEO at BC3 Technologies, designing products to save peoples lives.
Pacific Biosciences • Menlo Park • $148k – $222k • 3 days ago
Glaxosmithkline • Seattle • $158k – $264k • 3 days ago
Mindgrub Technologies • Baltimore • $60k – $70k • 3 days ago
Noble Biomaterials • Scranton • $64k – $84k • 6 days ago
Syndax Pharmaceuticals • New York City • 2 weeks ago